Full Text

Turn on search term navigation

Copyright © 2018 Catia A. Almeida et al. This is an open access article distributed under the Creative Commons Attribution License (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. http://creativecommons.org/licenses/by/4.0/

Abstract

Piper is the largest genus of the Piperaceae family. The species of this genus have diverse biological activities and are used in pharmacopeia throughout the world. They are also used in folk medicine for treatment of many diseases in several countries including Brazil, China, India, Jamaica, and Mexico. In Brazil, Piper species are distributed throughout the national territory, making this genus a good candidate for biological activity screening. During our studies with Piper essential oils, we evaluated its activity against Rhizopus oryzae, the main agent of mucormycosis. The main compounds of seven Piper essential oils analyzed were Piper callosum—safrole (53.8%), P. aduncum—dillapiole (76.0%), P. hispidinervum—safrole (91.4%), P. marginatum—propiopiperone (13.2%), P. hispidum—γ-terpinene (30.9%), P. tuberculatum—(E)-caryophyllene (30.1%), and Piper sp.—linalool (14.6%). The minimum inhibitory concentration of Piper essential oils against R. oryzae ranged from 78.12 to >1250 μg/mL. The best result of total inhibition of biofilm formation was obtained with Piper sp. starting from 4.88 μg/mL. Considering the bioactive potential of EOs against planktonic cells and biofilm formation of R. oryzae could be of great interest for development of antimicrobials for therapeutic use in treatment of fungal infection.

Details

Title
Piper Essential Oils Inhibit Rhizopus oryzae Growth, Biofilm Formation, and Rhizopuspepsin Activity
Author
Almeida, Catia A 1 ; Azevedo, Mariana M B 1   VIAFID ORCID Logo  ; Chaves, Francisco C M 2 ; Marcelo Roseo de Oliveira 2 ; Rodrigues, Igor A 3   VIAFID ORCID Logo  ; Bizzo, Humberto R 4 ; Gama, Paola E 4 ; Alviano, Daniela S 1 ; Alviano, Celuta S 1 

 Department of General Microbiology, Institute of Microbiology Paulo de Góes, Federal University of Rio de Janeiro (IMPG-UFRJ), CCS Ilha do Fundão, 21941-590 Rio de Janeiro, RJ, Brazil 
 EMBRAPA Western Amazon, Rodovia AM 10 km 29, 69010-970 Manaus, AM, Brazil 
 School of Farmacy, Department of Natural Products and Food, Federal University of Rio de Janeiro, CCS Ilha do Fundão, 21941-902 Rio de Janeiro, RJ, Brazil 
 EMBRAPA Food Technology, Avenida das Américas 29501, 23020-470 Rio de Janeiro, RJ, Brazil 
Editor
Mario Dell’Agli
Publication year
2018
Publication date
2018
Publisher
John Wiley & Sons, Inc.
ISSN
17129532
e-ISSN
19181493
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2070157810
Copyright
Copyright © 2018 Catia A. Almeida et al. This is an open access article distributed under the Creative Commons Attribution License (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. http://creativecommons.org/licenses/by/4.0/